---
title: "Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=761559"
source_layer: us_cdc_mmwr
category: outbreak_report
date: 2025-11-20
confidence: 中
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

This report describes a multicenter case-control investigation that found nirsevimab was 80% effective at preventing RSV-associated ICU admissions among infants.

## 詳細內容

This report describes a multicenter case-control investigation that found nirsevimab was 80% effective at preventing RSV-associated ICU admissions among infants.

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:08:58Z*
*資料來源: CDC MMWR*
